Ambar Protein Industries Ltd. - Research Center
519471 AMBARPIL Group (X) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
16.18 |
13.35 |
8.90 |
5.45 |
4.20 |
Secured loans
29.33 |
32.76 |
27.30 |
26.99 |
24.39 |
Unsecured loans
Total
51.26 |
51.85 |
41.95 |
38.19 |
34.34 |
Gross block
28.59 |
27.86 |
21.14 |
30.17 |
13.35 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
20.01 |
20.55 |
21.14 |
22.37 |
6.61 |
Capital work-in-progress
Investments
Current assets, loans & advances
42.25 |
43.57 |
28.86 |
26.95 |
30.91 |
Less : current liabilities & provisions
11.03 |
12.29 |
8.28 |
11.16 |
18.81 |
Total net current assets
31.22 |
31.28 |
20.58 |
15.79 |
12.09 |
Miscellaneous expenses not written
Total
51.26 |
51.85 |
41.95 |
38.19 |
34.34 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
57.50 |
57.50 |
57.50 |
57.50 |
57.50 |